Greg Stohr
Bloomberg
October 12, 2010

  • A d v e r t i s e m e n t
  • {openx:49}

The U.S. Supreme Court rejected an appeal from Pfizer Inc. and other makers of hormone replacement treatments, leaving intact a ruling that lets 123 women who developed breast cancer sue in Minnesota state court.

The appeal sought to reinstate a federal trial court ruling that dismissed 116 of the plaintiffs because their claims duplicated previously filed suits.

Fresh food that lasts from eFoods Direct (Ad)

The issue in the Supreme Court appeal turned on the complex rules governing efforts by corporate defendants to move suits out of plaintiff-friendly state courts and into federal tribunals.

Read Entire Article


NEWSLETTER SIGN UP

Get the latest breaking news & specials from Alex Jones and the Infowars Crew.

Related Articles


FROM AROUND THE WAR


Comments